SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

ITG, Inc. (ITG) News

Follow ITG, Inc. (ITG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ITG Asset equity Sector Markets 90 days 3 Last 5.72 Updated Nov 12, 2026, 11:17 AM UTC Open live news feed Open ITG chart & news
M ITG Reports Q3 Revenue of $461.5 Million, Raises 2026 Outlook Third-quarter 2026 revenue rose 49% year over year to $461.5 million. Adjusted EBITDA increased 64% to $64.5 million; ITG reported a $6.1 million net loss and $62.8 million in free cash flow. EQUITY | Nov 12, 2026, 11:17 AM UTC M ITG Reports Preliminary Third-Quarter Revenue and Adjusted EBITDA Above Outlook ITG said preliminary third-quarter revenue and Adjusted EBITDA were above its outlook. Full results and a conference call are scheduled for November 10 and 11, 2026, respectively. EQUITY | Oct 22, 2026, 08:43 PM UTC H CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Tuesday. Shares of Carmax Inc (NYSE: KMX ) rose sharply after the company reported better-than-expected second-quarter financial results. CarMax LIVE | Sep 29, 2026, 02:26 PM UTC L ITG reports Q2 results, raises 2026 growth outlook ITG said second-quarter revenue rose 38% year over year, adjusted EBITDA was $52.2 million, and it introduced 2026 guidance for 35% full-year revenue growth and 36% adjusted EBITDA growth. EARNINGS | Aug 13, 2026, 01:06 PM UTC L ITG Reports Second Quarter 2026 Results ITG, Inc. reports second quarter 2026 results EARNINGS | Aug 12, 2026, 08:08 PM UTC H Opening Day: Scribe Therapeutics makes strong trading debut Scribe Therapeutics makes its public debut above issue price as the CRISPR drug developer opened for trading last week. The biotech entered the market with cardiometabolic programs at the forefront and early momentum beh MNA | Jul 27, 2026, 03:21 PM UTC L ITG Initiate with a Buy, $16 PT @ Truist ITG Initiate with a Buy, $16 PT @ Truist EQUITY | Jul 27, 2026, 12:23 PM UTC L Top Initiations: BSP DFTX GHRS HELP MDGL: OVERWEIGHT @ WFC CMPS: EQUAL WEIGHT @ WFC CIFR HIVE PMN WULF: BUY @ Chardan BWXT CDRE LIME RYTM: O Top Initiations: BSP DFTX GHRS HELP MDGL: OVERWEIGHT @ WFC CMPS: EQUAL WEIGHT @ WFC CIFR HIVE PMN WULF: BUY @ Chardan BWXT CDRE LIME RYTM: OVERWEIGHT @ JPM CLH ITG: BUY @ BAC ARLO WSM: OVERWEIGHT @ Piper ADUR: BUY @ ROTH EQUITY | Jul 27, 2026, 11:09 AM UTC L ITG Initiated at Buy and $16 PT @ Stifel ITG Initiated at Buy and $16 PT @ Stifel EQUITY | Jul 27, 2026, 11:00 AM UTC L ITG int Outperform @ Baird pt $19 ITG int Outperform @ Baird pt $19 EQUITY | Jul 27, 2026, 09:45 AM UTC L ITG, Inc. initiated with bullish view at Morgan Stanley, here's why ITG, Inc. initiated with bullish view at Morgan Stanley, here's why EQUITY | Jul 27, 2026, 08:49 AM UTC L Opening Day: Bending Spoons tops pricing range in market debut Several companies made their market debuts last week, with Bending Spoons, ITG and Neutron Holdings opening for trading across a mix of pricing levels. LATEST IPOS AND DIRECT LISTINGS: Bending Spoons (BSP) opened on July MNA | Jul 06, 2026, 02:25 PM UTC L ITG Closes IPO, Raises Net Proceeds of $323.4 Million () -- ITG (ITG) said Thursday it closed its initial public offering of about 22.4 million Class A shares, including the full exercise of the underwriters' option to purchase additional shares at $16.00 each. The communic EQUITY | Jul 02, 2026, 09:05 PM UTC L ITG IPO Opens For Trade At $18/Share; IPO Priced At $16/Share On 19,512,196 Shares ITG IPO Opens For Trade At $18/Share; IPO Priced At $16/Share On 19,512,196 Shares EQUITY | Jul 01, 2026, 04:27 PM UTC L Reported Earlier, Show moreITG Prices Initial Public Offering Of 19,512,196 Shares Of Class A Common Stock At $16.00 Per Share Reported Earlier, Show moreITG Prices Initial Public Offering Of 19,512,196 Shares Of Class A Common Stock At $16.00 Per Share EQUITY | Jul 01, 2026, 07:49 AM UTC